Watch Demo

Generics in Scandinavia

Generics in Scandinavia

  • Publish Date:August 2020

  • Number of Pages:41

  • Report ID:3695760

  • Format:PDF

  • Publisher:MarketLine

$ 350

Summary

Generics in Scandinavia

Summary
Generics in Scandinavia industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the ’generic-eligible’ market, are not included.
- The Scandinavian generics market had total revenues of $2.7bn in 2019, representing a compound annual growth rate (CAGR) of 4.2% between 2015 and 2019.
- Market consumption volume increased with a CAGR of 2% between 2015 and 2019, to reach a total of 48.3% in 2019.
- The Danish market is the largest in the region accounting for 44.5%, followed by Sweden, Finland, and Norway which make up 23.5%, 20.3% and 11.7% respectively.

Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in Scandinavia
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Scandinavia
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Scandinavia generics market with five year forecasts by both value and volume

Reasons to Buy

- What was the size of the Scandinavia generics market by value in 2019?
- What will be the size of the Scandinavia generics market in 2024?
- What factors are affecting the strength of competition in the Scandinavia generics market?
- How has the market performed over the last five years?
- How large is Scandinavia’s generics market in relation to its regional counterparts?

Table of contents

1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape

2 Market Overview
2.1. Market definition
2.2. Market analysis

3 Market Data
3.1. Market value
3.2. Market volume

4 Market Segmentation
4.1. Geography segmentation

5 Market Outlook
5.1. Market value forecast
5.2. Market volume forecast

6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. How has the outbreak of COVID-19 impacted leading players?

8 Company Profiles
8.1. Teva Pharmaceutical Industries Limited
8.2. Mylan N.V.
8.3. Pfizer Inc.
8.4. Sanofi SA

9 Appendix
9.1. Methodology
9.2. About MarketLine

List of Tables
Table 1: Scandinavia generics market value: $ million, 2015-19
Table 2: Scandinavia generics market volume: % of total pharma, 2015-19
Table 3: Scandinavia generics market geography segmentation: $ million, 2019
Table 4: Scandinavia generics market value forecast: $ million, 2019-24
Table 5: Scandinavia generics market volume forecast: % of total pharma, 2019-24
Table 6: Teva Pharmaceutical Industries Limited: key facts
Table 7: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 8: Teva Pharmaceutical Industries Limited: Key Employees
Table 9: Mylan N.V.: key facts
Table 10: Mylan N.V.: Annual Financial Ratios
Table 11: Mylan N.V.: Key Employees
Table 12: Pfizer Inc.: key facts
Table 13: Pfizer Inc.: Annual Financial Ratios
Table 14: Pfizer Inc.: Key Employees
Table 15: Pfizer Inc.: Key Employees Continued
Table 16: Sanofi SA: key facts
Table 17: Sanofi SA: Annual Financial Ratios
Table 18: Sanofi SA: Key Employees
Table 19: Sanofi SA: Key Employees Continued

List of Figures
Figure 1: Scandinavia generics market value: $ million, 2015-19
Figure 2: Scandinavia generics market volume: % of total pharma, 2015-19
Figure 3: Scandinavia generics market geography segmentation: % share, by value, 2019
Figure 4: Scandinavia generics market value forecast: $ million, 2019-24
Figure 5: Scandinavia generics market volume forecast: % of total pharma, 2019-24
Figure 6: Forces driving competition in the generics market in Scandinavia, 2019
Figure 7: Drivers of buyer power in the generics market in Scandinavia, 2019
Figure 8: Drivers of supplier power in the generics market in Scandinavia, 2019
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Scandinavia, 2019
Figure 10: Factors influencing the threat of substitutes in the generics market in Scandinavia, 2019
Figure 11: Drivers of degree of rivalry in the generics market in Scandinavia, 2019

Companies Mentioned
• Teva Pharmaceutical Industries Limited
• Mylan N.V.
• Pfizer Inc.
• Sanofi SA

Methodology

Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.

The data is gathered from a wide range of sources, including industry reports, government statistics, and company financials. This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary interviews are conducted with industry experts and key stakeholders to gather their insights and perspectives on the market. This information is then combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis is also carried out to understand the impact of external factors on the market. Finally, country-level data analysis is performed to understand the market dynamics in specific regions and countries.

Reportlinker's market research methodology is designed to provide clients with a clear understanding of the market, its trends, and its future potential.